Trials / Completed
CompletedNCT05609266
Validation of Existing Diabetes Risk Models in a Swedish Population
Validation of Non-invasive Risk Models for Prediction of Incident Type 2 Diabetes in a Swedish Population
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 115,642 (actual)
- Sponsor
- Umeå University · Academic / Other
- Sex
- All
- Age
- 28 Years – 62 Years
- Healthy volunteers
- Accepted
Summary
The goal of this observational study is to validate existing non-invasive diabetes clinical prediction models in a Swedish population. The main question it aims to answer is: how well 11 existing models will perform in predicting incident type 2 diabetes in participants from the Västerbotten Intervention programme (VIP). Participants in VIP are residents of Västerbotten that are invited for a comprehensive health screening at 30- (until 1995), 40-, 50-, and 60-years of age.
Detailed description
Several type 2 diabetes risk prediction models have been developed but how it will perform in a Swedish population is not known. No diabetes risk prediction model is routinely used in Sweden. The aim of this study is therefore, to validate 11 non-invasive models and to evaluate the performance to predict incident type 2 diabetes in a Swedish population. A population-based cohort from the Västerbotten Intervention programme (VIP) from 1990 to 2020 will be the validation sample. Incident type 2 diabetes within 10-years of follow-up, will be determined by oral glucose tolerance test or through self-reports. A self-administered questionnaire is completed, and anthropometric, clinical, and biochemical measures are obtained at each of the health screening visits. In the statistical analysis the overall performance of the models will be compared using the Brier score. In addition. discrimination and calibration of all the models will be evaluated. Recalibration of models will be done.
Conditions
Timeline
- Start date
- 1990-01-01
- Primary completion
- 2020-12-01
- Completion
- 2020-12-01
- First posted
- 2022-11-08
- Last updated
- 2022-12-02
Source: ClinicalTrials.gov record NCT05609266. Inclusion in this directory is not an endorsement.